Mark Kaye sold $1.9M of ELV
EVP & CFO at Elevance Health, Inc.. 4,588 shares at an average of $424.82, traded Apr 24, 2025, filed Apr 25, 2025.
Score components
- +22RoleCFO
- +25Trade size$1.9M at market
- +5Share of holdings soldSold 19% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001156039-25-000060, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | SOpen-market sale Common Stock | -4,588 | $424.82 | $1.9M | 18,977 | Apr 25, 2025 |
Related signals
Other insiders at Elevance Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | Elevance Health, Inc. | Amy W Schulman director | $7,475 26 shares | -11% | |
| 52Moderate | Elevance Health, Inc. | Charles Morgan Kendrick JR EVP & President, Commercial | $911k 3,196 shares | -21% | |
| 66Notable | ELVbuy Elevance Health, Inc. | Steven H Collis director | $870k 3,000 shares | +469% | |
| 48Moderate | ELVbuy Elevance Health, Inc. | Susan D. DeVore director | $375k 1,200 shares | +52% | |
| 71Notable | ELVbuy Elevance Health, Inc. | Gail Boudreaux President and CEO | $2.4M 8,500 shares | +6% | |
| 40Moderate | Elevance Health, Inc. | Ronald W Penczek CAO & Controller | $184k 443 shares | -19% | |
| 58Moderate | Elevance Health, Inc. | Charles Morgan Kendrick JR EVP & President, Commercial | $1.4M 3,504 shares | -26% | |
| 50Moderate | ELVsell Elevance Health, Inc. | Charles Morgan Kendrick JR EVP & President, Commercial | $3.2M 7,417 shares | -47% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.